Benzinga | Nov 10, 2021 07:54AM EST

Werewolf Therapeutics Q3 EPS $(0.51) Up From $(6.61) YoY

Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.51) per share. This is a 92.28 percent increase over losses of $(6.61) per share from the same period last year.